Form 4 for MRNA Moderna
Accepted 2023-03-09 00:00:00 ET · period of report 2023-03-07 · accession 0001127602-23-009563 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-09 | 2023-03-07 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | +1,138 | 6,381 | +22% | $0 |
| D | 2023-03-09 | 2023-03-08 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $141.51 | -561 | 5,820 | -9% | -$79.4K |
| D | 2023-03-09 | 2023-03-07 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | -1,138 | 10.2K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-07 | M | A | 1,138 | $0.00 | 6,381 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-08 | S | D | 561 | $141.51 | 5,820 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-03-07 | M | D | 1,138 | $0.00 | 10,248 | D | $0.00 · 2022-06-07 to — | 1,138 Common Stock | (F3) 25% of the shares subject to this restricted stock unit award vested on June 7, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |